A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor ...
A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor ...
MIAMI, FL, April 30, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high ...
Co announces data from a preclinical study on its Selective Androgen Receptor Modulator LGD-3303 at the American Society for Bone and Mineral Research Annual Meeting in Honolulu, Hawaii on Sept 16, ...
Co announces that it has licensed from Bristol-Myers Squibb (BMY) a selective androgen receptor modulator program, including a lead compound in Phase 1 clinical development and back-up compounds.
Hormone therapy is commonly used in cancers that rely on specific hormones for growth, most notably breast and prostate ...
Memorial Hospital for Cancer and Allied Diseases and Memorial Sloan Kettering Cancer Center have jointly developed new nonsteroid selective androgen receptor modulators (SARMs) and radiolabeled ...
Forget the clanging barbells and endless protein shakes. Enter the realm of SARMs, where cutting-edge science meets bodybuilding ambition. These Selective Androgen Receptor Modulators are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback